Cargando…

A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol

BACKGROUND: Anthracyclines and monoclonal antibodies against human epidermal growth factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated with risk of developing cardiotoxicity. Implementation of cardioprotective strategies as part of breast cancer treatment are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz-Balboa, Estíbaliz, González-Salvado, Violeta, Rodríguez-Romero, Beatriz, Martínez-Monzonís, Amparo, Pedreira-Pérez, Milagros, Palacios-Ozores, Patricia, López-López, Rafael, Peña-Gil, Carlos, González-Juanatey, José R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025895/ https://www.ncbi.nlm.nih.gov/pubmed/33827450 http://dx.doi.org/10.1186/s12872-021-01970-2

Ejemplares similares

Thirty-second sit-to-stand test as an alternative for estimating peak oxygen uptake and 6-min walking distance in women with breast cancer: a cross-sectional study
por: Díaz-Balboa, Estíbaliz, et al.
Publicado: (2022)

ONCOR: design of the Dutch cardio-oncology registry
por: Kamphuis, J. A. M., et al.
Publicado: (2020)

Comparison of dosimetric characteristics of Siemens virtual and physical wedges for ONCOR linear accelerator
por: Attalla, Ehab M., et al.
Publicado: (2010)

Monte Carlo Simulation of Siemens ONCOR Linear Accelerator with BEAMnrc and DOSXYZnrc Code
por: Jabbari, Keyvan, et al.
Publicado: (2013)

Effects of the COVID-19 pandemic on offering and acceptance in a cardiac rehabilitation programme: introduction of a remote CR programme
por: Sestayo Fernandez, M, et al.
Publicado: (2022)

Dosimetry and evaluating the effect of treatment parameters on the leakage of multi leaf collimators in ONCOR linear accelerators
por: Jabbari, Keyvan, et al.
Publicado: (2016)

Collision indicator charts for gantry‐couch position combinations for Siemens ONCOR and Elekta Infinity linacs
por: Becker, Stewart J., et al.
Publicado: (2013)

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
por: Collomb, Bastien, et al.
Publicado: (2022)

Dose linearity and uniformity of Siemens ONCOR impression plus linear accelerator designed for step-and-shoot intensity-modulated radiation therapy
por: Bhangle, Janhavi R., et al.
Publicado: (2007)

A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
por: de la Fuente, Ana, et al.
Publicado: (2022)

Aging, cardiotoxicity, and chemotherapy
por: Bocchi, Edimar Alcides, et al.
Publicado: (2019)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity
por: Eiras, Sonia, et al.
Publicado: (2020)

A clinician-to-clinician universal electronic consultation programme at the cardiology department of a Galician healthcare area improves healthcare accessibility and outcomes in elderly patients
por: Mazón-Ramos, Pilar, et al.
Publicado: (2023)

Omentin protects H9c2 cells against docetaxel cardiotoxicity
por: Lage, Ricardo, et al.
Publicado: (2019)

A cardiotoxicity dataset for breast cancer patients
por: Piñeiro-Lamas, Beatriz, et al.
Publicado: (2023)

Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe: A Randomized Clinical Trial
por: Snoek, Johan A., et al.
Publicado: (2020)

Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
por: Gillespie, Hamilton S, et al.
Publicado: (2011)

Chemotherapy-Induced Cardiotoxicity: Pathophysiology and Prevention
por: CSAPO, MELINDA, et al.
Publicado: (2014)

Pediatric Chemotherapy Drugs Associated With Cardiotoxicity
por: Hitawala, Gazala, et al.
Publicado: (2021)

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine
por: Viswanathan, Thyla, et al.
Publicado: (2021)

Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy
por: Gabani, Mohanad, et al.
Publicado: (2021)

Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
por: Gavila, J., et al.
Publicado: (2016)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
por: Radulescu, Liliana Maria, et al.
Publicado: (2021)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022)

Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation
por: Lage, Ricardo, et al.
Publicado: (2023)

Cardiotoxicity in cancer patients treated with chemotherapy: A systematic review
por: Lima, Maria Adriely Cunha, et al.
Publicado: (2022)

Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy
por: Moscoso, Isabel, et al.
Publicado: (2022)

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
por: Khattry, Navin, et al.
Publicado: (2009)

Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
por: Angsutararux, Paweorn, et al.
Publicado: (2015)

Physiopathology and diagnosis of cardiotoxicity in patients submitted to chemotherapy treatment
por: Marmelo, Filipe C., et al.
Publicado: (2019)

Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancer
por: Alıcı, Hayri, et al.
Publicado: (2015)

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
por: Legi, Ashiq, et al.
Publicado: (2021)

The Value of Troponin as a Biomarker of Chemotherapy-Induced Cardiotoxicity
por: Sorodoc, Victorita, et al.
Publicado: (2022)

Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021)

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.
por: de Graaf, H., et al.
Publicado: (1997)

Cancer chemotherapy induces cardiotoxicity by targeting cardiac stem cells
por: Li, Yong-mei, et al.
Publicado: (2010)

Cardiac Sympathetic Hyperactivity after Chemotherapy: Early Sign of Cardiotoxicity?
por: Guimarães, Sarita Lígia Pessoa de Melo Machado, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rjj9a49c7bf9qc3r046p3ces6g